Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid: Modulating effects of dihydroxylated vitamin D3, α interferon and 'stem cell factor'

Leukemia Research

Volumn 21, Issue 1, 1997, Pages 51-58

  Ferrero, Dario ^a   Carlesso, Nadia ^a,b   Bresso, Paola ^a   Roux, Viviana ^a   Pregno, Patrizia ^a,c   Gallo, Eugenio ^a,c   Pileri, Alessandro ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

interferon; Acute myeloid leukemia; Clonogenic cells; Dihydroxylated vitamin D3; Retinoic acid; Stem cell factor

Indexed keywords

ALPHA INTERFERON; DIHYDROXYCOLECALCIFEROL; RECOMBINANT ALPHA2B INTERFERON; RETINOIC ACID; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CHOLECALCIFEROL; HUMANS; INTERFERON ALFA-2B; LEUKEMIA, MYELOID; MIDDLE AGED; STEM CELL FACTOR; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031037073     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00066-5     Document Type: Article

References (41)

1. 1. Sachs L. (1987) The molecular control of blood cell development. Science 238, 1374.
2. 2. Chomienne C. (1991) Low dose chemotherapy and differentiating agents. Balliere's Clin. Haematol. 4, 47.
3. 3. Koeffler H. P. (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62, 709.
4. 4. Ferrero D., Pessano S., Pagliardi G. L. & Rovera G. (1983) Induction of differentiation of human myeloid leukemias: surface changes probed with monoclonal antibodies. Blood 61, 171.
5. 5. Chomienne S., Ballerini P., Balitrand N., Daniel M. T., Fenaux P., Castaigne S. & Degos L. (1990) All-trans retinoic acid in acute promyelocytic leukemia. II. In vitro studies: structure-function relationship. Blood 76, 1710.
6. 6. Pegoraro L., Abrahm J., Cooper R. A., Levis A., Lange B., Meo P. & Rovera G. (1980) Differentiation of human leukemias in response to 12-O-tetradecanoylphorbol-13-acetate in vitro. Blood 55, 859.
7. 7. Koeffler P. H., Hirji K. & Itri L. (1985) 1,25-Dihydroxy vitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat. Rep. 69, 1399.
8. 8. Perussia B., Dayton E. T., Fanning V., Thiagarajan P., Hoxie J. & Trinchieri G. (1983) Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J. exp. Med. 158, 2058.
9. 9. Koeffler H. P., Yelton L., Prokocimer M. & Hirji K. (1985) Study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate. Leukemia Res. 9, 73.
10. 10. McCulloch E. A. (1984) The blast cells of acute myeloblastic leukemia. In Cell Culture Techniques, Vol. 13, Clinics in Haematology (McCulloch E. A., Ed.), p. 503. Saunders, London.
11. 11. Griffin J. D. & Lowenberg B. (1986) Clonogenic cells in acute myeloblastic leukemia. Blood 68, 1185.
12. 12. Douer D. & Koeffler H. P. (1982) Retinoic acid: inhibition of the clonal growth of human myeloid leukemia cells. J. Clin. Invest. 69, 277.
13. 13. Munker R., Norman A. & Koeffler P. (1986) Vitamin D compounds: effects on clonal proliferation and differentiation of human myeloid cells. J. Clin. Invest. 78, 424.
14. 14. Ferrero D., Carlesso N., Pregno P., Gallo E. & Pileri A. (1992) Self-renewal inhibition of acute myeloid leukemia clonogenic cells by biological inducers of differentiation. Leukemia 6, 100.
15. 15. Howell A. L., Stukel T. A., Bloomfield C. D., Davey F. R. & Ball E. D. (1990) Induction of differentiation in blast cells and leukemic colony-forming cells from patients with acute myeloid leukemia. Blood 75, 721.
16. 16. Santini V., Colombat P. H., Delwel R., Van Gurp R., Touw J. & Lowenberg B. (1991) Induction of granulocytic maturation in acute myeloid leukemia by G-CSF and retinoic acid. Leukemia Res. 15, 341.
17. 17. Hunter A. E., Rogers S. Y., Roberts I. A. G., Barrett A. J. & Russell N. (1993) Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 82, 899.
18. 18. Nara N., Curtis J. E., Senn J. S., Tritchler D. L. & McCulloch E. A. (1986) The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Blood 67, 762.
19. 19. Breitman T. R., Collins S. J. & Keene B. R. (1981) Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57, 1000.
20. 20. Huang M. E., Yu-Chen Y., Shu-Rong C. S. R., Chai J. R., Lu J. X., Lin Z., Long J. & Wang Z. Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567.
21. 21. Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P. & Degos L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76, 1704.
22. 22. Warrel R. P. Jr, Frankel S. R., Miller W. H. Jr, Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S. & Dmitrovsky E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324, 1385.
23. 23. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F. & Pelicci P. G. (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood 83, 10.
24. 24. Collins S. (1987) The HL 60 promyelocytic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 70, 1233.
25. 25. Dalton W. T. Jr, Ahearn M. J., McCredie K. B., Freireich E. J., Stass S. A. & Trujillo J. M. (1988) HL60 cell line was derived from a patient with F.A.B.-M2 and not F.A.B. M3. Blood 71, 242.
26. 26. Kizaki M., Koeffler H. P., Lin C. W. & Miller C. W. (1990) Expression of retinoic acid receptor mRNA in hematopoietic cells. Leukemia Res. 14, 645.
27. 27. Hassan H. & Rees J. (1988) Retinoic acid, alone and in combination with cytosine-arabinoside, induces differentiation of human myelo-monocytic and monoblastic leukaemic cells. Hematol. Oncol. 6, 39.
28. 28. Wang C., Koistinen P., Yang G. S., Williams D. E., Lyman S. D., Minden M. D. & McCulloch E. A. (1991) Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 5, 493.
29. 29. Carlesso N., Pregno P., Bresso P., Gallo E., Pileri A., Zsebo K. & Ferrero D. (1992) Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia 6, 642.
30. 30. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R. & Sultan C. (1976) Proposals for the classification of acute leukemias. Br. J. Haematol. 33, 451.
31. 31. Tarella C., Ferrero D., Caracciolo D., Badoni R., Bellone G. & Gallo E. (1988) Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factors. J. Clin. Lab. Immunol. 25, 185.
32. 32. Welte K., Platzer E., Lu L., Gabrilove J., Levi E., Mertelsman R. & Moore M. A. S. (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony stimulating factor. Proc. natn. Acad. Sci. U.S.A. 82, 1526.
33. 33. Segal A. W. (1974) Nitroblue-tetrazolium test. Lancet ii, 1248.
34. 34. Koeffler H. P. & Amatruda T. (1985) The effects of retinoids on haemopoiesis; clinical and laboratory studies. In Retinoids, Differentiation and Disease (Nugent J. & Clark S., Eds), p. 252. Ciba Foundation, London.
35. 35. Smith M. A., Parkinson D. R., Cheson B. D. & Friedman M. A. (1992) Retinoids in cancer therapy. J. Clin. Oncol. 10, 839.
36. 36. Lippman S., Kavanagh J., Paredes-Espinoza M., Delgadillo-Madruno F., Paredes-Casillas P., Wuan K. H., Holdener E. & Krakoff I. E. (1992) 13-cis retinoic acid plus interferon-alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J. natn. Cancer Inst. 84, 241.
37. 37. Preisler H. D., Raza A. & Larson R. A. (1992) Alteration in the proliferative rate of acute myelogenous leukemia cells in vivo in patients. Blood 80, 2600.
38. 38. Ferrero D., Gallo E., Bruno B., Pregno P., Stefani S., Ciravegna G., Vietti-Ramus G., Luraschi A. & Pileri A. (1994) Differentiating agents and low dose 6-thioguanine for poor prognosis myelodysplastic syndromes and acute myeloid leukemia. Haematol. suppl. (abstr. 67) 4, 65.
39. 39. Ferrero D., Bruno B., Pregno P., Stefani S., Larizza E., Ciravegna G., Luraschi A., Vietti-Ramus G., Schinco P., Bazzan M., Gallo E. & Pileri A. (1996) Combined differentiating therapy for myelodysplastic syndromes. Leukemia Res. 20, 867.
40. 40. Tallman M. S., Miller H. J., Zanzig C., Rademaker A., Gordon L., Hakimian D., Variakojis D., Stiff P., French S. & Benson III A. B. (1994) All-trans retinoic acid (ATRA), low-dose cytosine-arabinoside (LD Ara-C) and granulocyte-colony stimulating factor (G-CSF) in relapsed and refractory acute myelogenous leukemia (AML): an Illinois Cancer Center phase II pilot study. Blood (abstr. 1231) 84 (suppl. 1), 311.
41. 41. Lawrence H. J., Conner K., Kelly M. A., Haussler M. R., Wallace P. & Bagby G. C. (1987) Cis retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood 69, 302.